Communications biology · 2022
Adaptive laboratory evolution in S. cerevisiae highlights role of transcription factors in fungal xenobiotic resistance.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ottilie Sabine, Luth Madeline R, Hellemann Erich, Goldgof Gregory M, Vigil Eddy, Kumar Prianka, Cheung Andrea L, Song Miranda, Godinez-Macias Karla P, Carolino Krypton, Yang Jennifer, Lopez Gisel, Abraham Matthew, Tarsio Maureen, LeBlanc Emmanuelle, Whitesell Luke, Schenken Jake, Gunawan Felicia, Patel Reysha, Smith Joshua, Love Melissa S, Williams Roy M, McNamara Case W, Gerwick William H, Ideker Trey, Suzuki Yo, Wirth Dyann F, Lukens Amanda K, Kane Patricia M, Cowen Leah E, Durrant Jacob D, Winzeler Elizabeth A
Аннотация
In vitro evolution and whole genome analysis were used to comprehensively identify the genetic determinants of chemical resistance in Saccharomyces cerevisiae. Sequence analysis identified many genes contributing to the resistance phenotype as well as numerous amino acids in potential targets that may play a role in compound binding. Our work shows that compound-target pairs can be conserved across multiple species. The set of 25 most frequently mutated genes was enriched for transcription factors, and for almost 25 percent of the compounds, resistance was mediated by one of 100 independently derived, gain-of-function SNVs found in a 170 amino acid domain in the two Zn2C6 transcription factors YRR1 and YRM1 (p < 1 × 10-100). This remarkable enrichment for transcription factors as drug resistance genes highlights their important role in the evolution of antifungal xenobiotic resistance and underscores the challenge to develop antifungal treatments that maintain potency.